David Windley
Stock Analyst at UBS
(3.64)
# 818
Out of 5,090 analysts
198
Total ratings
67.26%
Success rate
14.45%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DEO Diageo | Downgrades: Neutral | n/a | $89.49 | - | 1 | Dec 3, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $317 → $409 | $333.49 | +22.64% | 27 | Oct 17, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $541.06 | -16.83% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $224.92 | +0.04% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $185.45 | -5.63% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $14.48 | -34.37% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $184.04 | +5.96% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $261.02 | +0.76% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.45 | +89.66% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $38.85 | +57.01% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $17.18 | -30.15% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $419 → $253 | $253.02 | -0.01% | 18 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $268.42 | +57.22% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $150.57 | +97.25% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.88 | +326.67% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $333.49 | +81.11% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $568.65 | -34.05% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $16.50 | -6.03% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $242.28 | +11.44% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.57 | +62.05% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $281.77 | +90.23% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $22.92 | +26.53% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.78 | +3,087.66% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.33 | - | 5 | Oct 9, 2017 |
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $89.49
Upside: -
UnitedHealth Group
Oct 17, 2025
Maintains: Buy
Price Target: $317 → $409
Current: $333.49
Upside: +22.64%
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $541.06
Upside: -16.83%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $224.92
Upside: +0.04%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $185.45
Upside: -5.63%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $14.48
Upside: -34.37%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $184.04
Upside: +5.96%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $261.02
Upside: +0.76%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.45
Upside: +89.66%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $38.85
Upside: +57.01%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $17.18
Upside: -30.15%
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $253.02
Upside: -0.01%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $268.42
Upside: +57.22%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $150.57
Upside: +97.25%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.88
Upside: +326.67%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $333.49
Upside: +81.11%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $568.65
Upside: -34.05%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $16.50
Upside: -6.03%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $242.28
Upside: +11.44%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.57
Upside: +62.05%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $281.77
Upside: +90.23%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $22.92
Upside: +26.53%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.78
Upside: +3,087.66%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.33
Upside: -